Skip to content
Clinical Trials

- Designed as 20-patient pivotal study to be used for HDE application
- Pilot study converted to a pivotal probable benefit study
- Pilot study patients included in the 20
- Primary Endpoint (Objective Performance Criterion) – at least 25% of patients improve ASIA Impairment Scale (AIS) grade by 6 months
- Additional Endpoints: ISNCSCI sensory and motor scores, bladder and bowel function, Spinal Cord Independence Measure (SCIM III), pain, quality of life
- To learn more about our ongoing clinical study, visit: http://clinicaltrials.gov/ct2/show/study/NCT02138110